FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
216490NDAASCENDIS PHARMA BONE001YORVIPATHSOLUTION;SUBCUTANEOUSEQ 0.168MG TERIPARATIDE/0.56ML (EQ 0.168MG TERIPARATIDE/0.56ML)PALOPEGTERIPARATIDE2024-08-09PrescriptionYes
002YORVIPATHSOLUTION;SUBCUTANEOUSEQ 0.294MG TERIPARATIDE/0.98ML (EQ 0.294MG TERIPARATIDE/0.98ML)PALOPEGTERIPARATIDE2024-08-09PrescriptionNo
003YORVIPATHSOLUTION;SUBCUTANEOUSEQ 0.42MG TERIPARATIDE/1.4ML (EQ 0.3MG TERIPARATIDE/ML)PALOPEGTERIPARATIDE2024-08-09PrescriptionNo
761177BLAASCENDIS PHARMA ENCOCRINOLOGY DIV A/S001SKYTROFAINJECTABLE;INJECTION3MGLONAPEGSOMATROPIN-TCGD2021-08-25PrescriptionNo
002SKYTROFAINJECTABLE;INJECTION3.6MGLONAPEGSOMATROPIN-TCGD2021-08-25PrescriptionNo
003SKYTROFAINJECTABLE;INJECTION4.3MGLONAPEGSOMATROPIN-TCGD2021-08-25PrescriptionNo
004SKYTROFAINJECTABLE;INJECTION5.2MGLONAPEGSOMATROPIN-TCGD2021-08-25PrescriptionNo
005SKYTROFAINJECTABLE;INJECTION6.3MGLONAPEGSOMATROPIN-TCGD2021-08-25PrescriptionNo
006SKYTROFAINJECTABLE;INJECTION7.6MGLONAPEGSOMATROPIN-TCGD2021-08-25PrescriptionNo
007SKYTROFAINJECTABLE;INJECTION9.1MGLONAPEGSOMATROPIN-TCGD2021-08-25PrescriptionNo
008SKYTROFAINJECTABLE;INJECTION11MGLONAPEGSOMATROPIN-TCGD2021-08-25PrescriptionNo
009SKYTROFAINJECTABLE;INJECTION13.3MGLONAPEGSOMATROPIN-TCGD2021-08-25PrescriptionNo